And

are now a part of the new and improved

Advertisement

Dermwire News

News | April 19, 2019

Fibrocell to Collaborate with Castle Creek Pharmaceuticals to Develop and Commercialize RDEB Gene Therapy

Fibrocell Science, Inc. has entered into a collaboration agreement with Castle Creek Pharmaceuticals to develop and commercialize Fibrocell’s lead gene therapy candidate, FCX-007, for the treatment of recessive dystrophic...

Read More

News | April 24, 2019

Ovation Science Appoints Medical Dermatology Advisory Board

Ovation Science, Inc. has entered into an exclusive agreement with Skincareguide.com Ltd., to act as the Company's Medical Dermatology Advisory Board for cannabis formulated products. The objective of the Medical Dermatology Advisory...

Read More

News | April 15, 2019

A Conserved Stress Response May Fuel Resistance to BRAF Inhibitors in Melanoma

Moffitt Cancer Center researchers have discovered a mechanism by which melanoma cells become resistant to drugs that target the BRAF protein and its signaling pathway. Their study was published online in the journal Cancer...

Read More

News | April 15, 2019

InMode Launches AccuTite, the Smallest RFAL Treatment for Face and Body

InMode Ltd. is introducing AccuTite, the smallest Radio-Frequency Assisted Lipolysis (RFAL) device for precision fat reduction or skin contraction in the face and body. With its sub-millimeter cannula, AccuTite enables focal RF...

Read More

News | March 28, 2019

PALLAS Ti: Sapphire Solid State Laser Shows Similar Efficacy and Safety to 308nm Excimer Laser for Localized Vitiligo

A novel 311nm Titanium:Sapphire UV laser demonstrates comparable efficacy and safety when compared to 308nm excimer laser in the treatment of localized vitiligo, according to a study recently published in Lasers in Surgery and...

Read More

Advertisement

The Latest News

Advertisement

View more

Advertisement